Changes in EU Put Pricing, Reimbursement at Forefront
By Nuala Moran
Monday, June 25, 2012
BOSTON It's a long path from all the fascinating science discussed at BIO last week to getting a new drug into the hands of patients, and now in Europe, convulsions in the pricing and reimbursement environment are stretching the time from discovery to first revenues even further.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.